Company Revenue

The company's spine business grew in the high single digits for FY 3Q22 as the company prepares to make overall...

The company grew in the high single-digits in 2021 and is ready to expand into other areas of spine as...

The company finished 2021 near its pre-pandemic levels but named a new CEO to face mounting challenges in orthopedics....

The company grew +49% in 2021 as it continued integrating its recent acquisitions ahead of its spin-off as Enovis at...

Dr. Deepak Nath has been appointed as the company’s new Chief Executive Officer, succeeding Roland Diggelmann....

The company's knee and hip replacement sales remain impacted by surgical restrictions, but its foot and ankle line continued its...

The company grew over 21% in 2021 as it took share from larger competitors. Globus expects to surpass the $1...

The company grew in the mid-single digits for FY3Q21 as market recovery in Japan and abroad has helped Seikagaku increase...

The company grew in the low double digits for 2021 compared to 2020. but expects 2022 to be flat at...

Stryker reported 4Q21 orthopedic sales of $2.4 billion, +13.8% vs. 4Q20. For the full year of 2021, the company's orthopedic...